The role of Lipoxin A4 in cystic fibrosis lung disease

8Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In Cystic Fibrosis (CF), mutations of the CFTR gene result in defective Cl-secretion and Na+ hyperabsorption by epithelia which leads to airway lumen dehydration and mucus plugging and favours chronic bacterial colonization, persistent inflammation and progressive lung destruction. Beyond this general description, the pathogenesis of CF lung disease remains obscure due to an incomplete understanding of normal innate airway defense. This mini-review aims to highlight the role of the pro-resolution lipid mediator, Lipoxin A4, which is inadequately produced in CF, on several aspects of innate immunity that are altered in CF airway disease. © 2013 Urbach et al.

Cite

CITATION STYLE

APA

Urbach, V., Higgins, G., Buchanan, P., & Ringholz, F. (2013). The role of Lipoxin A4 in cystic fibrosis lung disease. Computational and Structural Biotechnology Journal, 6(7), e201303018. https://doi.org/10.5936/csbj.201303018

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free